302 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author이승욱-
dc.date.accessioned2016-11-03T02:37:19Z-
dc.date.available2016-11-03T02:37:19Z-
dc.date.issued2015-04-
dc.identifier.citation대한비뇨기종양학회지, v. 13, NO 1, Page. 29-34en_US
dc.identifier.issn1598-8341-
dc.identifier.issn2233-5633-
dc.identifier.urihttp://www.kjuo.or.kr/-
dc.identifier.urihttp://hdl.handle.net/20.500.11754/24126-
dc.description.abstractPurpose: It has been reported in several for factors on the drug compliance of patients, number of drug being taken, symptom, and pharmaceutical dosage form. However, Studies of drug compliance by dosing methodologies of tamsulosin, finasteride combination therapy and symptom relief for benign prostatic hyperplasia has not been performed. Therefore, we studied for symptom and differences in medication adherence in method of administration of tamsulosin, finasteride combination therapy. Materials and Methods: The groups were consisted in need of combination therapy of tamsulosin, finasteride on benign prostatic hyperplasia, one had packaged both drugs together (Group A, n=30) and the other were individually packaged both agents (Group B, n=30). International Prostatic Symptom Score (IPSS) were checked on first, 4weeks, and 8weeks. The evaluation was carried out of medicine compliance by checking the number of drugs 4weeks-interval. which was every 4weeks during 8weeks. Results: The properties other than the PSA in both groups, there was no statistically significant differences between patients. In first 4weeks, drug compliance of each Group A and B had tamsulosin 82.6%, 93.3% (p=0.033), finasteride 80.1%, 93.3% (p=0.042), and last 4weeks tamsulosin 80.6%, 93.7% (p=0.013), finasteride 79.5%, 93.7% (p=0.002) were checked. Group C, D had 81.4%, 96.4% (p=0.021) on 4weeks, 80.6%, 97.2% (p=0.011) on 8weeks. Conclusions: For co-administration of finasteride and tamsulosin are required in patients with benign prostatic hyperplasia, in order to enhance drug compliance, both tablets have to prescript together in one package to be taken at one time is useful.en_US
dc.language.isoko_KRen_US
dc.publisher대한비뇨기종양학회en_US
dc.subjectProstatic hyperplasiaen_US
dc.subjectComplianceen_US
dc.subjectTamsulosinen_US
dc.subjectFinasterideen_US
dc.title전립선비대증의 치료로 Tamsulosin, Finasteride 병합요법시 투여 방법 및 증상호전에 따른 약물 순응도의 차이 분석en_US
dc.title.alternativeSymptom and Differences in Medication Adherence in Method of Administration of Tamsulosin, Finasteride Combination Therapy in Benign Prostatic Hyperplasiaen_US
dc.typeArticleen_US
dc.relation.no1-
dc.relation.volume13-
dc.relation.page29-34-
dc.relation.journal대한비뇨기종양학회지-
dc.contributor.googleauthor김규식-
dc.contributor.googleauthor정재훈-
dc.contributor.googleauthor김태효-
dc.contributor.googleauthor이기수-
dc.contributor.googleauthor이승욱-
dc.contributor.googleauthorKim, Kyu Shik-
dc.contributor.googleauthorChung1, Jae Hoon-
dc.contributor.googleauthorKim, Tae Hyo-
dc.contributor.googleauthorLee, Ki Soo-
dc.contributor.googleauthorLee, Seung Wook-
dc.relation.code2012215889-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidswleepark-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE